Table 1.
Patients' characteristics and the proportion of patients who received appropriate thromboprophylaxis.
| Patients' characteristics | Overall (n = 396) | Patients with appropriate VTE prophylaxis |
| Data are presented as means ± SD or n (%). *Refers to patients were classified as high risk for VTE if their Padua score was ≥ 4. BMI: body mass index; VTE: venous thromboembolism. | ||
| Number of patients | 396 (100.0%) | 288 (72.7%) |
| Age, yrs | 75.0 ± 9.1 | 76.0 ± 9.0 |
| Female gender | 171 (43.2%) | 129 (44.8%) |
| BMI, kg/m2 | 27.1 ± 7.4 | 26.6 ± 7.5 |
| High risk of VTE* | 284 (71.7%) | 268 (93.1%) |
| Pre-existing comorbidities | ||
| Hypertension | 314 (79.3%) | 230 (79.9%) |
| Diabetes mellitus | 300 (75.8%) | 216 (75.0%) |
| Chronic kidney disease | 140 (35.4%) | 103 (35.8%) |
| Obesity, BMI > 30 kg/m2 | 117 (29.5%) | 82 (28.5%) |
| Heart failure | 101 (25.5%) | 77 (26.7%) |
| Thyroid disorder | 50 (12.6%) | 37 (12.8%) |
| Active cancer | 36 (9.1%) | 33 (11.5%) |
| History of VTE | 36 (9.1%) | 33 (11.5%) |
| Thrombophilic condition | 7 (1.8%) | 5 (1.7%) |
| Reason for admission | ||
| Pneumonia | 72 (18.2%) | 54 (18.8%) |
| Urinary tract infection | 44 (11.1%) | 40 (13.9%) |
| Stroke | 40 (10.1%) | 29 (10.1%) |
| Respiratory diseases | 30 (7.6%) | 25 (8.6%) |
| Sepsis | 23 (5.8%) | 21 (7.3%) |
| Decompensated heart failure | 16 (4.0%) | 10 (3.5%) |
| Acute kidney injury | 15 (3.8%) | 10 (3.5%) |
| Other | 156 (39.4%) | 99 (34.3%) |
| VTE prophylaxis used | ||
| Heparin | 313 (79.0%) | 236 (81.9%) |
| Enoxaparin | 54 (13.6%) | 38 (13.2%) |
| Mechanical | 7 (1.8%) | 5 (1.7%) |
| None | 22 (5.6%) | 7 (3.1%) |